ABBOTT LABORATORIES — Director's Dealing 2007

Feb 22, 2007

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2007-02-16

Reporting Person: Bohuon Olivier (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2007-02-17	Common shares without par value	A	4167	$52.49	Acquired	24997	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2007-02-16	Option (right to buy)	$52.54	A	83000	Acquired	2017-02-15	common shares (83000)	Direct
2007-02-16	Restricted Stock Unit	$0	A	17000	Acquired		common shares (17000)	Direct

Footnotes

F1: Settlement of a performance-based restricted stock unit in shares in a transaction exempt from Section 16(b) under Rule 16b-3.

F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 27,667 on 2/16/2008, 27,667 on 2/16/09, and 27,666 on 2/16/10.

F3: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program. The units generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Each unit represents the contingent right to receive one Abbott common share.